These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 35449431)

  • 21. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.
    Kaiserman K; Jung H; Benabbad I; Karges B; Polak M; Rosilio M
    Pediatr Diabetes; 2017 Mar; 18(2):81-94. PubMed ID: 27390032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.
    Meiffren G; Herbrand T; Anastassiadis E; Klein O; DeVries JH; Heise T; Alluis B; Mégret C; Gaudier M; Soula O; Plum-Mörschel L
    Diabetes Obes Metab; 2019 Jul; 21(7):1570-1575. PubMed ID: 30828929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria.
    Bohn B; Kerner W; Seufert J; Kempe HP; Jehle PM; Best F; Füchtenbusch M; Knauerhase A; Hofer M; Rosenbauer J; Holl RW;
    Diabetes Res Clin Pract; 2016 May; 115():31-8. PubMed ID: 27242120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal insulin replacement and use of rapid-acting insulin analogues in patients with type 1 diabetes.
    Zinman B
    Endocr Pract; 2000; 6(1):88-92. PubMed ID: 11419927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study.
    Piras de Oliveira C; Mitchell BD; Fan L; Garey C; Liao B; Bispham J; Vint N; Perez-Nieves M; Hughes A; McAuliffe-Fogarty A
    Curr Med Res Opin; 2021 Jan; 37(1):45-51. PubMed ID: 33108218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database Analysis.
    Wang K; Chen Y; Strizek A; Boye K; Gu L; Liu Y; Qu S
    Clin Ther; 2019 Oct; 41(10):2057-2065. PubMed ID: 31514971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients.
    Hirsch IB; Yuan H; Campaigne BN; Tan MH
    Endocr Pract; 2009; 15(4):343-8. PubMed ID: 19454394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin initiation in patients with type 2 diabetes is often delayed, but access to a diabetes nurse may help-insights from Norwegian general practice.
    Mdala I; Nøkleby K; Berg TJ; Cooper J; Sandberg S; Løvaas KF; Claudi T; Jenum AK; Buhl ES
    Scand J Prim Health Care; 2024 Mar; 42(1):132-143. PubMed ID: 38116986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020.
    Rodríguez Escobedo R; Lambert C; Morales Sánchez P; Delgado Álvarez E; Menéndez Torre E
    Diabetol Metab Syndr; 2023 May; 15(1):90. PubMed ID: 37138364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study.
    Nakanishi S; Shimoda M; Tatsumi F; Kohara K; Obata A; Sanada J; Fushimi Y; Anno T; Kawasaki F; Mune T; Kaku K; Kaneto H
    Diabetes Ther; 2021 Jul; 12(7):1849-1860. PubMed ID: 34047960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.
    Newson RS; Divino V; Boye KS; Chen J; DeKoven M; Vallarino C; Ranta K; Mount JE
    Diabetes Ther; 2024 Jun; 15(6):1435-1449. PubMed ID: 38683494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes.
    Haller MJ; Jones MC; Bhavsar S; Kaiserman KB
    Diabetes Ther; 2023 Mar; 14(3):611-617. PubMed ID: 36652106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Adjuvant Medications on A1C, Body Mass Index, and Insulin Requirements among Patients with Type 1 Diabetes.
    Silva Almodóvar A; Clevenger J; Nahata MC
    Pharmacy (Basel); 2022 Aug; 10(4):. PubMed ID: 36005937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EFFICACY AND SAFETY OF BASAL INSULIN THERAPY IN ROMANIAN PATIENTS WITH TYPE 2 DIABETES IN REAL-LIFE SETTINGS: A SUB-GROUP ANALYSIS OF DUNE STUDY.
    Cerghizan A; Amorin P; Catrinoiu D; Creteanu G; Adamescu E; Moise M
    Acta Endocrinol (Buchar); 2020; 16(1):43-48. PubMed ID: 32685037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pen needle use patterns in an insured population with diabetes: US retrospective claims analysis.
    Lupton L; Sun X; Javadi P; Goldman JD; Cornell S; Fernandes J; Kishorekumar S; Thach A; Sieradzan R
    J Am Pharm Assoc (2003); 2024 May; ():102124. PubMed ID: 38759794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study.
    Wu J; Morrison F; Zhao Z; Haynes G; He X; Ali AK; Shubina M; Malmasi S; Ge W; Peng X; Turchin A
    Clin Diabetes Endocrinol; 2021 Jan; 7(1):1. PubMed ID: 33402226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.